General Information of Drug (ID: DM75PHJ)

Drug Name
MK-8655
Indication
Disease Entry ICD 11 Status REF
Type-2 diabetes 5A11 Phase 1 [1]
Cross-matching ID
TTD ID
D03BZS

References

1 ClinicalTrials.gov (NCT01640873) Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002 AM1). U.S. National Institutes of Health.